فهرست مطالب z. pourhabib

Considering the radioactivity of radiopharmaceuticals compounds, there are strict rules and regulations regarding their quality control aspects. One of the essential parameters in quality control is to determine the type and amount of radiopharmaceuticals impurities in order to ensure the prescribing of the correct dose. Impurity values are usually small, but these small amounts are also important and should be measured with high accuracy. The purpose of this study is to evaluate the simultaneous production of 186Re and 188Re with one target material and to investigate the production of probable impurities. To achieve the goal of this research, the work was carried out in two phases. In phase 1, a model based on the MCNPX code is designed to simulate target irradiation. In phase 2, the experimental assessment will be carried out using natural rhenium irradiation in Tehran research reactor. Both simulation and practical results showed that 186Re and 188Re can be produced with appropriate and nearly equal activities, simultaneously. Also, the amount of impurities is negligible compared to the main products. Our findings indicated that experimental data are in good agreement with simulation data (bias error less than 5%) and as a result, the simulation method is the powerful and useful technique to investigate different aspects of radioisotope production in reactor.

These days, the use of Rhenium 186 and 188 radionuclides in the production of various radiopharmaceuticals has grown considerably. These two radionuclides have good features such as emitting beta particles with appropriate range and energy, and gamma rays for imaging and evaluating biological distribution in cancer treatment. Regarding the energy and range of these radionuclides, Rhenium 186 with small range is suitable for treating small tumors; and Rhenium 188 with greater range is appropriate to destroy large tumors. In this study, the simultaneous production of these two radionuclides by natural rhenium irradiation for the production of a combined radiopharmaceutical, to treat tumors with various sizes has been investigated. For the purpose of this study, the irradiation of 1 mg of natural rhenium in a neutron flux of 3×1013 cm-2s-1 for 7 days was evaluated and the activity of the main products was calculated. Since the presence of impurities delivers an unwanted and excess dose to the patient, the presence and activity level of these radionuclides have also been studied. The results of the study showed that by the irradiation of natural rhenium, Rhenium 186 and 188 radionuclides can be produced simultaneously with the appropriate activity level for using the combination of both radionuclides. Also, theoretical calculations showed that the amount of produced impurities compared to the original products is negligible.